Family perspectives in lynch syndrome becoming a family at risk, patterns of communication and influence on relations
© Bartuma et al.; licensee BioMed Central Ltd. 2012
Received: 27 March 2012
Accepted: 10 May 2012
Published: 25 May 2012
A growing number of individuals are diagnosed with hereditary cancer. Though increased levels of anxiety and depression have been demonstrated around the time of genetic counselling, most individuals handle life at increased risk well. Data have, however, been collected on individual basis, which led us to focus on family perspectives of hereditary cancer.
Lynch syndrome represents a major type of hereditary colorectal and gynaecological cancer. We preformed open-ended interviews with 27 informants from 9 Lynch syndrome families. Inductive content analysis revealed three major themes: transition to a risk family, patterns of communication and influence on family relations and individual roles.
Family members described how learning about Lynch syndrome shifted focus from daily issues to concerns about cancer. Changes in communication related to difficulties in talking to children about heredity and informing new family members and distant relatives about an increased risk of cancer. Influence on relations was exemplified by family members taking on different roles, e.g. females often being responsible for coordinating information about heredity and providing support. Families in which members had experienced cancer at young age typically informed children soon after learning about heredity and at young age, whereas families with experience of cancer at higher age postponed information and thereby also genetic counselling.
Three major family perspectives are described in Lynch syndrome families; becoming a risk family, patterns of communication and influence on family relations. Since these issues are central, our findings suggests that such family perspectives should be considered during genetic counselling in order to contribute to information spread, help family members cope with the increased risk, and motivate family members at risk to undergo surveillance.
KeywordsFamily Relations Communication Lynch syndrome Qualitative analysis
Lynch syndrome is one of the most common causes of hereditary cancer  with particularly high risks for colorectal cancer (50–80%) and endometrial cancer (40–60%) [2, 3]. The syndrome is characterized by early age (mean 45 years) at onset, but age at onset varies, which implies that individuals in the same family may be affected at young age as well as at higher age. Moreover, 1/3 develops more than one cancer, whereas at least 1 on 5 remain healthy despite the high risk of cancer. Identification of Lynch syndrome families is crucial since surveillance programs efficiently reduce morbidity and mortality from cancer [4–6]. Studies of the psychological impact of hereditary cancer demonstrate temporarily increased anxiety after genetic counselling with most patients thereafter returning to base-line. Some 10% of the patients, however, find knowledge about hereditary cancer difficult to handle and report an impact on e.g. sense of coherence and self-concept .
Though information about a disease predisposing mutation has bearing not only for the individual, but also for family members, studies on the psychological effects of hereditary cancer have considered the individual’s views, which led us to investigate family perspectives of Lynch syndrome. Whether affected or not, family members will have to deal with information about heredity, worry for cancer development and concern for children. Information about an increased risk of cancer is generally communicated by family members, which makes information sharing vulnerable to personal interpretations and family relations [8, 9]. A number of factors facilitate information spread, e.g. open communication, positive attitudes, well-functioning relations, and support from the partner [8, 10]. In contrast, suboptimal communication, poor family relations and decisions to restrict disclosure of information may hamper information spread [9, 11]. Family structure and function may not only influence how family members receive information, but also how knowledge about an increased risk is handled, decisions related to genetic testing and participation in surveillance [8, 10, 12]. With the aim to explore family perspectives, we interviewed 27 members of Lynch syndrome families with focus on how family members perceived that knowledge about hereditary cancer has affected the family.
Young adults (not yet tested)
Parents with children
Informants with children living at home
Informants with grandchildren
Personal history of cancer
Data collection and analysis
Open-ended interviews were conducted by KB and CC, neither of whom had been involved in genetic counselling. The majority of the informants were interviewed in a non-hospital setting and the interviews lasted 15–60 minutes. The initial question was “Can you tell me how heredity has affected your family, as you see it?” and was intended to encourage the informants to tell their personal story without the involvement of the interviewer. The interviews were audio-taped and then transcribed verbatim by a secretary and analyzed by inductive content analysis [13–15]. The text was sorted with the NVivo® software (NVivo qualitative data analysis software; QSR International Pty Ltd. Version 8, 2008). The interviewers (KB and CC) repeatedly read and re-read the transcribed texts and marked selected texts corresponding to the aim, and thereafter grouped these texts together based on their content under preliminary codes. The text under the codes was re-read and subthemes were assigned based on the content. At this point subthemes merged with others or new subthemes emerged. The themes and here under subthemes were finalized by all authors. Informants’ quotes (identified as family/informant, mutation status and age) are used to illustrate the content. Approval of the study was granted by the Lund University Ethics Committee (346/2007).
Three major themes were identified: transition to a risk family, patterns of communication and influence on family relations and individual roles.
Transition to a risk family
Even though members of several families had suspected heredity before the identification of a mutation, verification hereof was described to shift the focus from daily life issues to worries about cancer. The subthemes identified were related to how experience influences risk perception and motivates genetic testing and how an increased risk of cancer in children is handled.
Experience influences risk perception and motivates genetic testing
Risk perception was described to be influenced by experience of cancer in the family and shaped the family members expectations. A young adult described expecting to be affected by cancer at a high age, since her grandparents and other relatives had been older at the time of diagnosis.
"“My grandfather died of cancer as well. So I don’t know, I’ve always thought that when you get old, you get cancer and then you die” (3/27, not tested, 20 years)"
A father described how his daughter recognized the same symptoms of colon cancer as he had, which indeed led her to diagnosis:
"“/…/then we had the problem of our daughter starting to have stomach aches too/…/she was 24 years old/…/she could see the same symptoms that I had had” (9/24, mutation carrier, 62 years)"
A major motivator for genetic testing was concern for children. Some mutation carriers reported that the result of genetic testing could affect family planning. The decision to undergo genetic testing was also influenced by family experiences. Individuals in families with many affected relatives or where parents or children were affected at a younger age chose to undergo genetic testing at a young age, typically shortly after the identification of a disease predisposing mutation. In contrast, young individuals in families with few cases of cancer or families in which cancer had developed at an older age reported postponing genetic testing and surveillance:
"“You hear sometimes when my father goes to these kinds of examinations/…/yes that’s right…you have to check out whether you have this gene too!/…/then you forget about it just as easily again. Because it’s been this way since you were little so yeah, yeah it’s nothing for me, I’ll check it when I get older/…/” (3/26, not tested, 22 years)"
Handling an increased risk of cancer in children
All parents expressed concern for their children, including worries about cancer being diagnosed at a young age, participation in surveillance programs, frustration over young adults choosing not to undergo genetic testing and difficulties related to respecting independent decision:
"“I guess I was mostly concerned about passing it on to [daughter]. And if you couldn’t … why I couldn’t test my child for the mutation/…/That I would have to wait, because she might get cancer before she turns 18/…/It’s pretty easy to take a blood sample.” (17/6, non-carrier, 37 years)"
Whereas some parents were determined that children should be tested at age 18, others acknowledged their autonomy. The spouse of a deceased mutation carrier described how she was initially convinced that her children should be tested at age 18, but after genetic counselling grasped the complexity of the issue and realized their need for independent decisions in order to be able to handle the result.
Patterns of communication
All family members discussed how the increased risk of cancer was communicated in the family, reported strategies for informing family members and described communication as open or restricted.
Strategies for informing family members
Family members described difficulties in grasping the complexity of the issue and correctly forward information obtained during genetic counselling. Misconceptions were reported and can be exemplified by a father who was keen to test his son, although he was not a carrier, and a mother who referred to the many affected relatives and concluded that the risk of inheriting the mutation in their family exceeded 50%. Informants reported informing first-degree relatives and regarded it as the parents’ duty to inform children. Parents found it difficult to inform children, however, and had different views on when and how this should be done and expressed a need for updated information and support. In 4 families with few cancer cases, parents tended to inform their children later, because of uncertainty about what information to provide. As an example, a father described planning to talk to his daughter when she turned 18, but at that time felt uncertain of how to bring up the issue and postponed information, whereafter she learnt about Lynch syndrome herself at age 25. Families in which cancer had presented at a young age tended to inform children at a lower age, often referring to family history:
"“/…/dad’s mother actually also had the gene/…/then he [dad] was only 12 years old when she died/…/then dad got it and then his sister got it so it’s more like I’ve pointed out this way for them [the children] and shown that it can be positive to know in order to prevent.” (4/7, mutation carrier, 45 years)"
Open or restricted communication
Communication patterns differed within and between the families. Some families reported open communication, e.g. talking to children about heredity, informing new family members, being open about feeling sick and sharing surveillance results. Experiences of cancer were reported to lead to openness and increased awareness:
"“We’ve always been open in the family. We don’t hide anything from each other. Especially since we have experience since my mother has had cancer so many times/…/” (7/16, mutation carrier, 39 years)"
Other families described restricted communication, linked to dysfunctional relationships, as exemplified by a father and mutation carrier who after a divorce lost contact with his son and did not know whether he had undergone genetic testing. Carriers described difficulties in conveying information about genetic testing to relatives with whom they had little contact, which sometimes resulted in information arrest. Their first contact with a distant relative could refer to hereditary cancer, where after they lost contact and did not know whether the relative had undergone genetic testing or if the information had been further spread in the family:
"“I told her [cousin] what had happened [genetic test] and what it was and then she wanted to do the examination/…/Then I don’t know if she did it. I haven’t met her again and then she moved. It isn’t a cousin that I have contact with exactly.” (7/20, mutation carrier, 45 years)"
Other family members referred to shared experiences and chose to attend genetic testing together:
"“/…/it was my sister and I who were involved in this and I felt that I could have the discussion better with her, since we grew up with dad/…/” (4/7, mutation carrier, 45 years)"
Several family members described how they had talked about heredity when they first learned about it but as time went by discussed it only when informing new relatives or children and at the time of surveillance. At-risk individuals who had tested negatively perceived heredity as less relevant and chose not to be involved in disseminating information.
Influence on family relations and individual roles
Altered relations and roles were discussed by the families with referral to improved as well as impaired relations. Furthermore, reference was made to roles of coordinators and the importance of family support.
Improved and impaired relations
Learning about hereditary cancer was considered to influence family relations, though the impact was not necessarily negative. One family with experience of cancer at a young age described how family relations had improved thanks to altered priorities, i.e. not wasting energy on arguments. In contrast, guilt was referred to in relation to passing on a cancer-predisposing mutation as well as among individuals who did not inherit the mutation. Isolation and a negative influence on the marital relationship were described by a spouse:
"“I have seen a big change in her [wife] since the operation and it is not the change that I expected, it is quite the opposite actually/…/we are very hurt with each other and she has become isolated” (1/2, spouse, 51 years)"
Coordinators and family support
In several families, one person took on the responsibility for information and reminders about surveillance. In 8 of the 9 families, a female family member took up this role and this individual was typically a mutation carrier or an individual affected by cancer. . Indeed, one family described coordinated reporting of results from genetic testing and surveillance to a female mutation carrier who collected and updated the information. Coordination was by some of the individuals responsible described as demanding, e.g. related to providing support when family members fell ill:
"“Sometimes I also want to be able to be little and scared. But it doesn’t work. It’s…you take it for granted that you’ll have the strength to stand. I’ve had problems with this during periods when relatives have been sick, it easily becomes too much.” (5/10, spouse, 54 years)"
Support from family members was perceived as important in coping with risks posed by heredity. Spouses reported frequently worrying about their affected partner’s cancer risk and looking for signs of illness:
"“…I’ve always been worried about him [husband]…and I think I’ve been thinking more about it [brain tumor] than he has… when he sometimes says “my head is hurting in a strange way” …you know … stuff like that…I guess I’m a little too apprehensive” (6/18, spouse, 34 years)"
Principles for sharing genetic information with individuals outside of the families differed and was reported by 7/27 informants. Professional support was reported to positively influence adherence to surveillance and defined responsibility from one physician was reported to reduce distress.
We assessed family perspectives of hereditary cancer using open-ended interviews with 27 individuals from Lynch syndrome families. Transition to a family at increased risk, patterns of communication, impact on family relations and individual roles were identified as major themes. It should be stressed that there is a variety of outcomes in this kind of study and that counsellors should be aware of the individuality of family member’s responses. Learning about hereditary cancer had implications on several aspects, from worries about cancer to a communication burden. Experiential knowledge was important in this process. Families who had experienced cancer at a young age tended to inform children at a young age and encouraged genetic testing shortly after learning about heredity, which indicates illness and death as major motivators for genetic testing and surveillance . In contrast, individuals in families with few cancer cases or late onset reported finding it difficult to inform children and. young adults in such families expressed weak motivation and tended to postpone genetic testing and participation in surveillance programs. With increasing use of molecular screening and efficient prevention of cancer in families undergoing surveillance, present and future generations in Lynch syndrome families are likely to experience less cancer. Our findings suggest that extended information on the natural history of Lynch syndrome may be required to motivate individuals in such families for genetic testing and participation in surveillance programs [17, 18]. Experiences from routine examinations of patients with colorectal and endometrial cancer suggest that, although family history and analysis of tumor tissue suggested Lynch syndrome, only 1 in 5 patients made an appointment with a genetic counsellor [19, 20].
Individuals in families with Lynch syndrome are trusted with a large and complex information burden, which can be questioned since dissemination of information occurs through routes and methods determined by family members and is sensitive to personal interpretations and misunderstandings. Communication plays a significant role in managing life at increased risk of cancer and is likely linked to participation in surveillance programs and thereby to the possibilities of reducing morbidity and mortality from colorectal cancer [11, 21–25]. Misconceptions were identified among both carriers and non-carriers and were related to children’s risks and the outcome of genetic testing. Since misunderstandings can be resolved by updated information, continued contact with the families related to risk estimates and surveillance may be useful. Open communication has been found to facilitate the spread of information, reduce the risk of misconceptions and ease adjustment to difficult situations . Experience of cancer seems to facilitate openness, which has also been observed in hereditary breast and ovarian cancer [27, 28]. In contrast, poor communication is a major determinant of adverse consequences and lack of support from family members can increase vulnerability [26, 29].
The influence on family relationships was repeatedly referred to. Positive implications were more often described by carriers than non-carriers, which may reflect adaptation and coping [12, 30]. A minority of the families reported a negative impact, including isolation and guilt . Females often took on a coordinating and supportive role and may thus represent a target group for e.g. education regarding communication skills and updated information, which is consistent with observations that females are crucial in communicating genetic information [8, 31].
Genetic counselling emphasizes the individual’s decision to undergo genetic testing and surveillance, but at the same time family relations influence information spread, coping and adherence to surveillance. Perspectives related to becoming a risk family, altered relations and impact on relations was referred to by several family members suggesting that these issues could be relevant to discuss during genetic counselling. The observation that the families are left with a large information burden, which is typically centered around a female member underlines that knowledge about hereditary cancer is sensitive to communication skills and family relations. Our findings suggest a need for updated information and education, which could also counteract the observation that families with fewer cancer cases and later age at onset tend to postpone information, which may have undesired consequences related to the efficacy of surveillance.
Competing of interest
No part of these data have been sent or published elsewhere. None of the authors have any conflicts of interest.
KB designed the study, interviewed the participants, analyzed the data and drafted the manuscript. MN designed the study, analyzed the data and drafted the manuscript. CC designed the study, interviewed the participants, analyzed the data and drafted the manuscript. All authors read and approved the final manuscript.
This study was supported by The Nilsson Cancer Fund and the Kamprad Cancer Fund.
- de la Chapelle A: The incidence of Lynch syndrome. Fam Cancer 2005, 4: 233–237. 10.1007/s10689-004-5811-3PubMedView Article
- Stoffel E, Mukherjee B, Raymond VM, Tayob N, Kastrinos F, Sparr J, Wang F, Bandipalliam P, Syngal S, Gruber SB: Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology 2009, 137: 1621–1627. 10.1053/j.gastro.2009.07.039PubMedPubMed CentralView Article
- Barrow E, Robinson L, Alduaij W, Shenton A, Clancy T, Lalloo F, Hill J, Evans DG: Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations. Clin Genet 2009, 75: 141–149. 10.1111/j.1399-0004.2008.01125.xPubMedView Article
- Jarvinen HJ, Renkonen-Sinisalo L, Aktan-Collan K, Peltomaki P, Aaltonen LA, Mecklin JP: Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members. J Clin Oncol 2009, 27: 4793–4797. 10.1200/JCO.2009.23.7784PubMedView Article
- Barrow E, Alduaij W, Robinson L, Shenton A, Clancy T, Lalloo F, Hill J, Evans DG: Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations. Clin Genet 2008, 74: 233–242. 10.1111/j.1399-0004.2008.01035.xPubMedView Article
- Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH, Lynch P, Burke W, Press N: Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 2006, 296: 1507–1517. 10.1001/jama.296.12.1507PubMedView Article
- Vendel Petersen Helle DK, Bendahl Pär-Ola, Wong Jiahui, Carlsson Christina, Bernstein Inge, Esplen Mary Jane, Nilbert Mef: Validation of a Self-Concept Scale for Hereditary Nonpolyposis Colorectal Cancer in Different Nationalities. , ; 2010.
- Koehly LM, Peterson SK, Watts BG, Kempf KK, Vernon SW, Gritz ER: A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning. Cancer Epidemiol Biomarkers Prev 2003, 12: 304–313.PubMed
- Stoffel EM, Ford B, Mercado RC, Punglia D, Kohlmann W, Conrad P, Blanco A, Shannon KM, Powell M, Gruber SB, et al.: Sharing genetic test results in Lynch syndrome: communication with close and distant relatives. Clin Gastroenterol Hepatol 2008, 6: 333–338. 10.1016/j.cgh.2007.12.014PubMedPubMed CentralView Article
- McCann S, MacAuley D, Barnett Y, Bunting B, Bradley A, Jeffers L, Morrison PJ: Family communication, genetic testing and colonoscopy screening in hereditary non-polyposis colon cancer: a qualitative study. Psychooncology 2009, 18: 1208–1215. 10.1002/pon.1487PubMedView Article
- Forrest K, Simpson SA, Wilson BJ, van Teijlingen ER, McKee L, Haites N, Matthews E: To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clin Genet 2003, 64: 317–326. 10.1034/j.1399-0004.2003.00142.xPubMedView Article
- van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Brocker-Vriends AH, van Asperen CJ, Sijmons RH, Seynaeve C, van Gool AR, Klijn JG, Tibben A: Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study. Clin Genet 2007, 71: 35–42.PubMedView Article
- Elo S, Kyngas H: The qualitative content analysis process. J Adv Nurs 2008, 62: 107–115. 10.1111/j.1365-2648.2007.04569.xPubMedView Article
- Wilkinson S: Focus group research In Qualitative research : theory, method and practice. In . 2nd edition. Edited by: Silverman D. Sage Publications, London; 2004:378.
- Silverman D: Interpreting qualitative data. 3rd edition. Sage, London; 2006.
- Foster C, Watson M, Moynihan C, Ardern-jones A, Eeles R: Genetic testing for breast and ovarian cancer predisposition: cancer burden and responsibility. J Health Psychol 2002, 7: 469–484. 10.1177/1359105302007004627PubMedView Article
- Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P, De La Chapelle A, Mecklin JP: Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000, 118: 829–834. 10.1016/S0016-5085(00)70168-5PubMedView Article
- Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB, Daniels MS, White KG, Boyd-Rogers SG, Conrad PG, et al.: Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 2006, 354: 261–269. 10.1056/NEJMoa052627PubMedView Article
- South CD, Yearsley M, Martin E, Arnold M, Frankel W, Hampel H: Immunohistochemistry staining for the mismatch repair proteins in the clinical care of patients with colorectal cancer. Genet Med 2009, 11: 812–817. 10.1097/GIM.0b013e3181b99b75PubMedView Article
- Backes FJ, Leon ME, Ivanov I, Suarez A, Frankel WL, Hampel H, Fowler JM, Copeland LJ, O’Malley DM, Cohn DE: Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer. Gynecol Oncol 2009, 114: 486–490. 10.1016/j.ygyno.2009.05.026PubMedView Article
- McAllister M: Personal theories of inheritance, coping strategies, risk perception and engagement in hereditary non-polyposis colon cancer families offered genetic testing. Clin Genet 2003, 64: 179–189. 10.1034/j.1399-0004.2003.00133.xPubMedView Article
- d’Agincourt-Canning L: The effect of experiential knowledge on construction of risk perception in hereditary breast/ovarian cancer. J Genet Couns 2005, 14: 55–69. 10.1007/s10897-005-1500-0PubMedView Article
- Mesters I, Ausems M, Eichhorn S, Vasen H: Informing one's family about genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a retrospective exploratory study. Fam Cancer 2005, 4: 163–167. 10.1007/s10689-004-7992-1PubMedView Article
- Vos J, Menko F, Jansen AM, van Asperen CJ, Stiggelbout AM, Tibben A: A whisper-game perspective on the family communication of DNA-test results: a retrospective study on the communication process of BRCA1/2-test results between proband and relatives. Fam Cancer 2011, 10: 87–96. 10.1007/s10689-010-9385-yPubMedPubMed CentralView Article
- Hughes C, Lerman C, Schwartz M, Peshkin BN, Wenzel L, Narod S, Corio C, Tercyak KP, Hanna D, Isaacs C, Main D: All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results. Am J Med Genet 2002, 107: 143–150. 10.1002/ajmg.10110PubMedView Article
- van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Brocker-Vriends AH, van Asperen CJ, Sijmons RH, Seynaeve C, Van Gool AR, Klijn JG, Riedijk SR, et al.: A prospective study of the impact of genetic susceptibility testing for BRCA1/2 or HNPCC on family relationships. Psychooncology 2007, 16: 320–328. 10.1002/pon.1062PubMedView Article
- Peterson SK, Watts BG, Koehly LM, Vernon SW, Baile WF, Kohlmann WK, Gritz ER: How families communicate about HNPCC genetic testing: findings from a qualitative study. Am J Med Genet C Semin Med Genet 2003, 119C: 78–86. 10.1002/ajmg.c.10010PubMedView Article
- Mellon S, Berry-Bobovski L, Gold R, Levin N, Tainsky MA: Communication and decision-making about seeking inherited cancer risk information: findings from female survivor-relative focus groups. Psychooncology 2006, 15: 193–208. 10.1002/pon.935PubMedView Article
- Berry DS, Pennebaker JW: Nonverbal and verbal emotional expression and health. Psychother Psychosom 1993, 59: 11–19. 10.1159/000288640PubMedView Article
- Peterson SK: The role of the family in genetic testing: theoretical perspectives, current knowledge, and future directions. Health Educ Behav 2005, 32: 627–639. 10.1177/1090198105278751PubMedView Article
- Green RM, Thomas AM: Whose gene is it? A case discussion about familial conflict over genetic testing for breast cancer. J Genet Couns 1997, 6: 245–254. 10.1023/A:1025672421311PubMedView Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.